Chia-Hung Chen

Dr. Chen is focused on developing integrative platforms for biomedical applications. Compared with most platforms using gene sequence for quantitative biology, integrative functional assay offers unique advantages for the rapid characterization of biological samples for diagnosis and timely precision medicine. With the possibility of high-throughput biological sample screening and cell sorting using the integrative platform, statistically information could be obtained for effective quantitative biological analysis. For example, an intelligent system that integrated imaging technology, multiplexed chemical sensors and a computational data-analysis method was previously developed to analyze small amounts of physiological samples to determine the disease progression of individual patients with cancer. Before joining City University of Hong Kong, Dr. Chen worked at National University of Singapore and Massachusetts Institute of Technology. He received his Ph.D. degree at University of Cambridge. He earned his M.S. degree at Harvard University, and earned his B.S. degree at National Taiwan University.

Research Interest

• Microfluidic functional assays for precision medicine
• Quantitative single-cell biology via intelligent Drop-Screen
• Smart hydrogel- based technology
• Single cell drug screen for personalized therapeutics.
• Platform engineering for synthetic biology

Awards

• Lab on a Chip Emerging Investigator, 2018
• MicroTAS Presentation Award, 2010
• Cambridge Overseas Trust 2006-2009
• Overseas Research Studentship (Cambridge) 2006-2009
• Harvard Alumni Scholarship 2005

Companies

• Associate Professor City University of Hong Kong (2019)
• Assistant Professor National University of Singapore (2012 — 2019)
• PostDoc MIT (2010 — 2012)
• Research Assistant Mars (2006 — 2010)

Education

• Doctor of Philosophy (PhD) University of Cambridge (2006 — 2010)
• Master of Science (MS) Harvard University (2005 — 2006)
• Bachelor of Science (BS) National Taiwan University (2000 — 2004)